Folixapure (Shoreline Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Folixapure drug offered from Shoreline Pharmaceuticals, Inc.. This Vitamin D [Chemical/Ingredient],Vitamin D [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Shoreline Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Folic Acid, Vitamin D3
SUBSTANCE NAME: FOLIC ACID; VITAMIN D
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vitamin D [Chemical/Ingredient],Vitamin D [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2016-05-13
END MARKETING DATE: 0000-00-00


Folixapure HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFolixapure from Shoreline Pharmaceuticals, Inc.
LABELER NAME: Shoreline Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1; 125(mg/1; ug/1)
START MARKETING DATE: 2016-05-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69621-090_ac948f39-89b1-49d3-9706-30df30a5782f
PRODUCT NDC: 69621-090
APPLICATION NUMBER:

Other FOLIC ACID; VITAMIN D Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
PureTek CorporationDermacinRx PureFolix
Shoreline Pharmaceuticals, Inc.Folixapure
SolubiomixOrtho D